Zymeworks Inc. (ZYME) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

13/25

Growth 3 Margin 1 Expansion 4 Platform 2 Financial 3

latest quarter score

Earnings Reports

13
Zymeworks (ZYME) Q1 2026: $250M Milestone Windfall Anchors Royalty Model, Pipeline Optionality Expands
May 08, 2026
17
Zymeworks (ZYME) Q4 2025: $250M Royalty Note Unlocks Capital for Share Buybacks and Asset Expansion
March 02, 2026
13
Zymeworks (ZYME) Q3 2025: $25M Milestone From J&J Underscores Platform Value, Pipeline Execution
November 07, 2025
19
Zymeworks (ZYME) Q2 2025: $48.7M Revenue Surge Anchors Strategic Shift to Royalty-Driven Growth
August 07, 2025
14
Zymeworks (ZYME) Q1 2025: Milestones Drive $17M Revenue Gain, Extending Runway to 2027
July 05, 2025
Zymeworks (ZYME) Q4 2024: Accelerated IND Submission for ZW251 Highlights Strategic Pipeline Prioritization
March 05, 2025

Browse all companies